VistaGen Therapeutics Inc. Common Stock. Replay the stock market charts of VTGN day by day, back to 2003. Open long and short positions without spending any money. VistaGen Therapeutics Inc is a clinical-stage biopharmaceutical company that develops and commercializes product candidates for patients with central nervous system diseases. Its product AV-101 is currently being evaluated in a Phase 2 monotherapy study.
